The Itchy Dog Project

Identifying the appropriate treatment

The type of treatment selected must be tailored to the individual dog, with the most appropriate options identified during the diagnostic process. cAD is a life-long disease, the signs of which can change over time, so regular re-assessment of the dog and the treatment options is required [1].

There is no cure for cAD, but there are many different options for long-term control or reduction of the symptoms. These include allergen avoidance and skin barrier support. There is also a wide variety of medication available that can be tried to find the right solution for you and your dog. These include medication that alters the dog’s immune response - including steroids, immunosuppressant medication (ciclosporin and oclacitinib), allergen-specific immunotherapy, anti-itch medication Cytopoint, antihistamines, topical shampoos and essential fatty acids. 

Very often, dogs with cAD develop secondary skin infections that can usually be treated with topical shampoo or in more severe cases, antibiotics. However, where skin infections occur repeatedly it is essential to prevent infection through the use of shampoos, antibacterial wipes or medication prescribed by your vet.

Once your vet has checked for any secondary infections (such as yeast or bacteria) and treated them accordingly then remaining symptoms can be treated via an individualised treatment plan agreed upon between you and your vet. There are a variety of treatment options for cAD, which depend on the exact signs your dog presents with and how severe their problems are.

Skin barrier support

 

Allergen avoidance

 

Immunomodulatory medication

 

Allergen-specific immunotherapy

 

Antihistamines

 

Behavioural intervention

 

References

  1. Shaw, S. A therapeutic approach to allergic pruritus in the dog. In Pract.  35, 24–28 (2013)
  2. Hightower, K., Marsella, R. & Flynn-Lurie, A. Effects of age and allergen exposure on transepidermal water loss in a house dust mite-sensitized beagle model of atopic dermatitis. Vet. Dermatol. 21, 89–96 (2010)
  3. Piekutowska, A., Pin, D., Rème, C. A., Gatto, H. & Haftek, M. Effects of a Topically Applied Preparation of Epidermal Lipids on the Stratum Corneum Barrier of Atopic Dogs. J. Comp. Pathol. 138, 197–203 (2008)
  4. Tretter, S. & Mueller, R. S. The Influence of Topical Unsaturated Fatty Acids and Essential Oils on Normal and Atopic Dogs. J. Am. Anim. Hosp. Assoc. 47, 236–240 (2011)
  5. Olivry, T. et al. Treatment of canine atopic dermatitis: 2015 updated guidelines from the International Committee on Allergic Diseases of Animals (ICADA). BMC Vet. Res. 11, 210 (2015)
  6. Nuttall, T., Reece, D. & Roberts, E. Life-long diseases need life-long treatment: long-term safety of ciclosporin in canine atopic dermatitis. Vet. Rec.  174, 3–12 (2014)
  7. Cosgrove, S. B. et al. Long‐term compassionate use of oclacitinib in dogs with atopic and allergic skin disease: safety, efficacy and quality of life. Vet. Dermatol. 26, 171-e35 (2015)
  8. Olivry, T. et al. Treatment of canine atopic dermatitis: 2010 clinical practice guidelines from the International Task Force on Canine Atopic Dermatitis. Vet. Dermatol. 21, 233–248 (2010)
  9. Bäumer, W. et al. Lack of preventing effect of systemically and topically administered histamine H1 or H4 receptor antagonists in a dog model of acute atopic dermatitis. Exp. Dermatol. 20, 577–581 (2011).
  10. Nagata, M. et. al. Importance of psychogenic dermatoses in dogs with pruritic behavior. J. Am. Vet. Med. Assoc. 233(7): 1105-11 (2002)
  11. Harvey ND, Craigon PJ, Shaw SC, Blott SC, England GCW. Behavioural differences in dogs with atopic dermatitis imply stress could be a significant problem associated with chronic pruritus. Animals. 2019;9(10):813. Available from: https://www.mdpi.com/2076-2615/9/10/813
  12. Cafazzo, S. et. al. L. Behavioural and physiological indicators of shelter dogs' welfare: Reflections on the no-kill policy on free-ranging dogs in Italy revisited on the basis of 15 years of implementation. Physiology & Behavior. 133, 223–229 (2014)

The Itchy Dog Project

School of Veterinary Medicine and Science
University of Nottingham
Sutton Bonington Campus
Leicestershire, LE12 5RD


email: itchydogproject@nottingham.ac.uk